In a report released yesterday, Alec Stranahan from Bank of America Securities maintained a Buy rating on Crispr Therapeutics AG (CRSP – ...

CRISPR Therapeutics AG (CRSP) closed the most recent trading day at $38.36, moving -1.26% from the previous trading session.

Crispr Therapeutics AG (CRSP) stock saw a decline, ending the day at $38.85 which represents a decrease of $-0.84 or -2.12% from the prior close of $39.69. The stock opened at $39.06 and touched a low ...

Leerink Partners analyst Mani Foroohar has maintained their bullish stance on CRSP stock, giving a Buy rating on January 13.Stay Ahead of the ...

VUG ETF invests in large-cap growth stocks. Check out 3 key reasons why the fund might not be a good choice from a portfolio ...

Brookstone Capital Management raised its holdings in Vanguard Mega Cap Growth ETF (NYSEARCA:MGK – Free Report) by 12.1% ...

The Vanguard US Total Market Shares Index ETF (ASX: VTS) outperformed the Vanguard Australian Shares Index ETF (ASX: VAS) by ...

A smart beta exchange traded fund, the iShares Core High Dividend ETF (HDV) debuted on 03/29/2011, and offers broad exposure to the Style Box - Large Cap Value category of the market. What Are Smart ...

Most still adhere to Vanguard's index-tracking roots – 78 out of the 88 ETFs follow benchmark indexes, with expense ratios as low as 0.03%. Even within this category, there's remarkable variety.

The U.S. Food and Drug Administration issued a proposed rule would limit the level of nicotine in cigarettes and certain other tobacco products if finalized, the agency said on Wednesday.

BlackRock said in its fourth-quarter earnings report Wednesday that assets under management jumped to a record $11.55 ...

U.S. federal prosecutors will not bring charges in the fatal 2019 arrest of unarmed Black motorist Ronald Greene, Greene's family said on Tuesday. United Statescategory Biden, Trump security ...